Source:http://linkedlifedata.com/resource/pubmed/id/10564528
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-11-30
|
pubmed:abstractText |
S100beta is an astrocyte-derived uritotrophic' cytokine which has been implicated in the pathogenesis of Alzheimer's disease. S100beta overexpression by plaque-associated astrocytes correlates with growth of abnormal (strophic') neurites in beta-amyloid plaques, one of the major neuropathological hallmarks of Alzheimer's disease. As the characteristic neuropathological changes of Alzheimer's disease are virtually universal in middle-aged Down's syndrome patients, studies of Down's syndrome patients provide a unique opportunity to investigate the pathophysiological processes underlying the development of Alzheimer-type neuropathological changes. Computerized morphometric analysis was used to quantify astrocyte activation and astrocytic expression of S100beta, and to correlate these with beta-amyloid deposition, in a clinically well-characterized cohort of Down's syndrome subjects, aged 13-65 years. There were significant positive correlations between S100beta expression and patient age, and between S100beta expression and cerebral cortical beta-amyloid deposition. Moreover, the numbers of activated (enlarged) astrocytes overexpressing S100beta showed a significant correlation with the numeric density of beta-amyloid plaques, from the youngest to the oldest ages and within age ranges where pathology is most florid, while no such relationship was found between the numbers of small, non-activated S100beta-immunoreactive cells and numerical density of beta-amyloid plaques. These correlations, together with established functions of S100beta, are consistent with the idea that S100beta overexpression promotes beta-amyloid plaque formation and progression in Down's syndrome.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0305-1846
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
387-93
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10564528-Adolescent,
pubmed-meshheading:10564528-Adult,
pubmed-meshheading:10564528-Aged,
pubmed-meshheading:10564528-Aging,
pubmed-meshheading:10564528-Amyloid beta-Peptides,
pubmed-meshheading:10564528-Astrocytes,
pubmed-meshheading:10564528-Down Syndrome,
pubmed-meshheading:10564528-Female,
pubmed-meshheading:10564528-Humans,
pubmed-meshheading:10564528-Image Processing, Computer-Assisted,
pubmed-meshheading:10564528-Immunohistochemistry,
pubmed-meshheading:10564528-Male,
pubmed-meshheading:10564528-Middle Aged,
pubmed-meshheading:10564528-Protein Isoforms,
pubmed-meshheading:10564528-S100 Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
|
pubmed:affiliation |
Department of Old Age Psychiatry, Park House, Hinchingbrooke Health Care NHS Trust, Cambridge, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|